Anti-Saccharomyces cerevisiae antibodies (ASCA) are immune antibodies directed against components of Saccharomyces cerevisiae, a yeast commonly found in foods such as bread, beer, wine, and nutritional yeast, as well as in the broader gut environment. ASCA does not measure the presence of the yeast itself, but rather the immune system’s response to it.
Under healthy conditions, the gut barrier prevents excessive immune exposure to dietary antigens and microbial components. When intestinal permeability is increased (often referred to as leaky gut), fragments of yeast and other microbes can cross the gut lining and trigger an immune response. Elevated ASCA levels therefore suggest loss of gut barrier integrity and heightened immune activation.
Clinically, ASCA is best known for its association with inflammatory bowel disease (IBD), particularly Crohn’s disease, but elevated levels can also be seen in individuals with chronic gut inflammation, dysbiosis, food sensitivities, or autoimmune tendencies. On functional stool and immune panels like the Gut Zoomer and Total Tox Burden, ASCA provides insight into how strongly the immune system is reacting to gut-derived antigens.
ASCA is interpreted in context with other findings such as microbial imbalances, inflammatory markers, digestive function, and additional immune antibodies. It is not a diagnostic marker on its own, but a signal of immune stress and barrier dysfunction within the gut.
Normal or low ASCA levels suggest appropriate immune tolerance to yeast-related antigens and generally indicate intact gut barrier function. In this context, immune reactivity to dietary or microbial yeast components is unlikely to be a primary driver of symptoms.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.